FDA Approves Topamax for Migraine Prevention in Ages 12-17
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Migraine.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Caroline Cassels, "Topiramate Safe, Effective for Migraine Prophylaxis in Adolescents," Medscape.com, July 10, 2008, http://www.medscape.com/viewarticle/577392, accessed April 1, 2014.
- Food and Drug Administration, "FDA approves Topamax for migraine prevention in adolescents," FDA.gov, March 28, 2014. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391026.htm.
- Gahan J. Padina, et al., "Cognitive Effects of Topiramate in Migraine Patients Aged 12 through 17 Years," Pediatr Neurol 2010 42:187-192.